William Blair has recently reduced Paragon 28 Inc (FNA) stock to Mkt Perform rating, as announced on Today, according to Finviz. Earlier, on Today, Needham had reduced the stock from a Buy to Hold. William Blair also initiated Outperform rating.

Paragon 28 (FNA – Research Report) received a Hold rating and price target from Needham analyst Michael Matson today. The company’s shares

Needham analysts revised their rating on Paragon 28 , Inc. (NYSE:FNA) stock, downgrading it from "Buy" to "Hold." According to InvestingPro data, the stock has shown strong momentum with a 38% return over the past six months,

Zimmer Biomet to buy medical device company, Paragon 28 for $1.2 billion: Warsaw, Indiana Thursday, January 30, 2025, 14:00 Hrs [IST] Zimmer Biomet Holdings, Inc., a global medica